| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_aaacf277d1ca555b6a99ad72dec179b3 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-205
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-40 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06 |
| filingDate |
2006-05-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2011-07-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7eeb749183265c8ee5828689a15b225a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9da3069bde290eddbbad6bbf9118e753
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f93b78845a474be75f7f35850f1439fe
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0fcfae040c4cc6f896347015f5addbff
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0fb63a697ee0b6592b546464f07dde8a |
| publicationDate |
2011-07-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CA-2621134-C |
| titleOfInvention |
Pharmaceutical formulation containing an hmg-coa reductase inhibitor and method for the preparation thereof |
| abstract |
The present invention relates to improved pharmaceutical formulation for oral administration comprising a therapeutically effective quantity of an HMG-CoA reductase inhibitor, and more particularly Fluvastatin, Atorvastatin or salts thereof in combination with a linear sulphated polysaccharide such as Carrageenan and a method for the preparation thereof. |
| priorityDate |
2006-05-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |